October 20, 2009
The U.S. Centers for Disease Control and Prevention allocated an additional 454,200 H1N1 vaccine doses to Texas last week bringing the total vaccine allocation for Texas to 960,400.
Last week’s allocation of doses included 233,100 of the injectable, or shot, form and 221,100 doses of the mist form.
Texas’ allocation for the week that ended Oct. 9 was 363,800 and included 235,000 doses of the injectable form and 128,800 doses of the mist form.
Texas’allocation for the week that ended Oct. 2 was 142,400 doses, all of it the nasal mist form of the vaccine.
Using a strategic approach to reach priority vaccine groups and subsets of those groups, DSHS has allocated the limited supply of vaccine to providers who serve pregnant women, children 2 years through 4 years of age, children 5 years through 18 years of age who are at higher risk of serious consequences should they get the flu and health care workers who provide direct patient care.
The 960,000 doses have been allocated to some 5,053 providers, with some of it distributed to local health departments as a safety net to meet special needs in communities. Some 12,000 Texas providers have registered to receive the vaccine.
The H1N1 vaccine distribution steps are:
- CDC allocates vaccine to the various state health departments each week.
- DSHS accepts the entire allocation and further apportions it to registered providers in Texas based on vaccine formulation, priority vaccination groups, geography and other factors.
- DSHS then notifies those providers to go online to confirm that they still want the vaccine, giving them a few days to confirm.
- Once confirmation is received, DSHS issues shipping instructions to a distributor to send the vaccine to the provider.
DSHS officials expect the weekly availability of the vaccine to be low for the next few weeks, adding that initial vaccine quantities are not high enough for public vaccination clinics to be held. They are urging providers and the public to be patient.
Texas expects to receive 15 million doses of the vaccine by the end of January.
(News Media Contact: Doug McBride, DSHS Press Officer, 512-458-7524.)
DSHS Press Office on Twitter